The current rally has been staged by retail traders, will they get burned, asks Joe Duarte.
This medical related stock could benefit from increased resources dedicated to dealing with the Coronavirus pandemic, reports Joe Duarte.
Investors who can adapt to the environment will have greater success than those who don’t, writes Joe Duarte.
The post new normal COVID-19 environment is creating new winners and losers, reports Joe Duarte.
A sustained rally in the face of a historic economic collapse is not sustainable, something will change, writes Joe Duarte.
The reality of the economic number is affecting the markets, economy life (MEL) dynamic, reports Joe Duarte.
Joe Duarte breaks down one stock likely to be a winner in the age of Coronavirus.
Markets and the coronavirus have us confused, be hopeful but cautious, advises Joe Duarte.
Here is a potential winner in the new normal from Joe Duarte.
We are in a period of a New “new normal,” so it is best to follow the trend while keeping are timeframe short, notes Joe Duarte.
Starbucks looking to buck analyst expectations, reports Joe Duarte.
Markets provide bulls the all-clear but there is still a lot of risk, reports Joe Duarte.
Markets have shown signs of optimism but haven't given the all-clear to bulls yet, reports Joe Duarte.
Micron may be at the head of the post-Coronavirus winners, writes Joe Duarte.
While the recent rebound was impressive, equity markets still have not provided an all-clear signal, reports Joe Duarte.
Either Starbucks executives are experiencing a bout of hubris or it is a strong play in the age of Coronavirus, reports Joe Duarte.
While there are some signs stocks are nearing a capitulation stage, it has not given the all clear to get back in yet, reports Joe Duarte.
There may be some bargains lurking on the market carnage of the last month, reports Joe Duarte.
No matter what, you can’t go wrong with lots of cash as there is no clear bottom in sight, writes Joe Duarte.
Gilead Sciences’ antiviral drug remdesivir is no vaccine, but it could help treat the Coronavirus while one is being developed, reports Joe Duarte.